Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 1/2024

Open Access 01.12.2024 | Research

The value of C-reactive protein, leucocytes and vital signs in detecting major complications after oncological colorectal surgery

verfasst von: Anke H. C. Gielen, Maud Schoenmakers, Stephanie O. Breukink, Bjorn Winkens, Jischmaël van der Horst, Kevin P. Wevers, Jarno Melenhorst

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 1/2024

Abstract

Purpose

To assess the association of postoperative C-reactive protein (CRP), leucocytes and vital signs in the first three postoperative days (PODs) with major complications after oncological colorectal resections in a tertiary referral centre for colorectal cancer in The Netherlands.

Methods

A retrospective cohort study, including 594 consecutive patients who underwent an oncological colorectal resection at Maastricht University Medical Centre between January 2016 and December 2020. Descriptive analyses of patient characteristics were performed. Logistic regression models were used to assess associations of leucocytes, CRP and Modified Early Warning Score (MEWS) at PODs 1–3 with major complications. Receiver operating characteristic curve analyses were used to establish cut-off values for CRP.

Results

A total of 364 (61.3%) patients have recovered without any postoperative complications, 134 (22.6%) patients have encountered minor complications and 96 (16.2%) developed major complications. CRP levels reached their peak on POD 2, with a mean value of 155 mg/L. This peak was significantly higher in patients with more advanced stages of disease and patients undergoing open procedures, regardless of complications. A cut-off value of 170 mg/L was established for CRP on POD 2 and 152 mg/L on POD 3. Leucocytes and MEWS also demonstrated a peak on POD 2 for patients with major complications.

Conclusions

Statistically significant associations were found for CRP, Δ CRP, Δ leucocytes and MEWS with major complications on POD 2. Patients with CRP levels ≥ 170 mg/L on POD 2 should be carefully evaluated, as this may indicate an increased risk of developing major complications.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Colorectal cancer (CRC) is currently the third most frequent form of malignancy. The incidence is predicted to increase in the coming years with an estimation of over 2 million new cases diagnosed worldwide annually by 2030 [1, 2]. Despite the development of the ‘Wait and See’ protocol as one of the regular treatment options for rectal cancer, surgical intervention remains the cornerstone in primary CRC treatment [3].
Postoperative infectious complications, especially anastomotic leakage, are the most prevalent and concerning complications following colorectal resections with a primary anastomosis [4, 5]. It is well-established that anastomotic leakage and its sequelae not only lead to increased short-term morbidity and mortality, but also have a negative impact on long-term oncological outcomes such as disease-free and overall survival [69]. Thus, early detection and adequate management of these complications are crucial for improving patient outcomes.
Previous studies have identified numerous biomarkers assisting in early diagnosis of anastomotic leakage and other major complications [10, 11]. C-reactive protein (CRP) currently is the gold standard [12]. Several cut-off points on postoperative days 3, 4 and 5 have been suggested and have demonstrated good diagnostic accuracy [10, 13]. However, the rate of change or trajectory of CRP levels may be more significant than the cut-off point alone [12, 14]. As an acute phase protein, CRP is affected not only by potential complications but also by the biological stress of the surgical procedure itself and peaks on the second postoperative day in all patients, regardless of complications [15, 16], resulting in a significantly increased specificity reaching 91% for CRP on the third postoperative day, in contrast to a specificity of 57% on POD 2 [17]. There is no consensus on the added value of leucocytes in the detection of complications [12, 18, 19].
Entering a new era of minimally invasive colorectal surgery, even striving for ambulatory surgery or same day discharge, the way of adequately monitoring our postoperative patients will have to change accordingly [20, 21]. We are considering the feasibility of orchestrating outpatient laboratory tests for CRP and/or leucocytes, or providing patients with biosensor monitoring at home [22].
In view of these knowledge gaps, we aim to assess the association of postoperative C-reactive protein (CRP), leucocytes and vital signs in the first three postoperative days (PODs) with major complications after oncological colorectal resections in a tertiary referral centre for colorectal cancer in The Netherlands.

Methods

Study design

An observational cohort study was conducted of all patients undergoing oncological colorectal resections in the Maastricht University Medical Centre + , a tertiary referral centre for colorectal cancer in The Netherlands. Included patients were treated between 1 January 2016 and 31 December 2020. In this period, the standard protocol of postoperative care in our hospital included daily laboratory tests (including CRP and leucocytes) in this patient population.
All oncological colorectal resections were eligible for inclusion. Criteria for exclusion were an age under 18, a benign indication for the colorectal resection and surgical procedures without (segmental) bowel resection or essential missing data in the electronic patient record.
Data were collected retrospectively from the electronic patient record using CTcue software (v3.1.0, CTcue B.V., Amsterdam, The Netherlands). Recorded data regarding baseline characteristics included patient age, sex, body mass index (BMI), smoking status, comorbidities and American Society of Anaesthesiologists (ASA) classification [23]. Both open, laparoscopic and robot-assisted procedures were included. Recorded clinical parameters included indication for operation, acute or elective procedure, type of surgery, duration of surgery (in minutes), primary anastomosis (yes/no), CRP and leucocytes in the first five postoperative days, the Modified Early Warning Score (MEWS) [24] measured in the morning of the first five postoperative days, complications according to the Clavien-Dindo classification [25] and length of hospital stay. Minor complications were defined as Clavien-Dindo grade I and II, major complications as Clavien-Dindo ≥ grade III. Complications were promptly registered upon their occurrence and diagnosis. A systematic evaluation of all complications took place on the day following the patients’ discharge and thoroughly discussed by the entire colorectal surgical staff in a daily meeting. The study protocol was assessed and approved by the medical ethics committee of the Maastricht University Medical Centre + (protocol number 2022–3598).

Statistical analysis

All statistical analyses were conducted in IBM SPSS Statistics (version 28: IBM Corporation, Armonk, NY, USA) after consulting a dedicated statistician. Clinical characteristics of the patients were described using mean and standard deviation (SD) or median and range (minimum–maximum) for numerical variables and number of patients with percentage for categorical ones. Cut-off points for the potential variables (CRP, leucocytes and MEWS) predictive for major complications were determined by receiver operating characteristic (ROC) curve. Optimal cut-off points were based on Youden’s J index, i.e. maximizing sum of sensitivity and specificity. Logistic regression analyses were used to assess associations of CRP, leucocytes and MEWS with the occurrence of major postoperative complications, with correction for potential confounders. This was done using the data of the first three PODs, since most patients without complications were already discharged on POD 3, or discharged without new laboratory testing on POD 4 or 5. The confounders were defined prior to the analyses and included age (years), sex (male or female), stage of disease (I, II, III or IV), BMI, diabetes mellitus and active smoking. Two-sided p-values ≤ 0.05 were considered statistically significant.

Results

In total, 594 patients were included. The population consisted of 340 (57.2%) male and 254 (42.8%) female patients with a mean age of 72.6 (SD 10.9) years (Table 1). Most patients underwent an oncological colorectal resection for CRC (N = 579, 97.5%), while four patients underwent the procedure for ovarian cancer, three for anal cancer, two for a lymphoma, two for a sarcoma, two for an appendiceal carcinoma, one for an intestinal melanoma and one for an endometrial carcinoma. Laparoscopic resections were performed in 353 (59.4%) cases, while robot-assisted procedures were performed in 22 (3.7%) cases (Table 2). In 64 (10.8%) cases, a primary laparoscopic procedure had to be converted to an open procedure. Primary open procedures were performed in 155 (26.1%) patients, predominantly in acute settings and in patients with locally advanced tumours. The majority of patients, 548 (92.3%), underwent an elective procedure, while 46 patients (7.7%) were operated on in an acute setting. The mean operating time was 210 (SD 92) minutes.
Table 1
Patient characteristics (N = 594)
Age in years, mean (SD1)
72.6 (10.9)
Sex, N (%)
  Male
340 (57.2%)
  Female
254 (42.8%)
BMI2 (kg/m2), mean (SD)
26.6 (5.3)
Active smoking, N (%)
  Yes
91 (15.3%)
  No
503 (84.7%)
Diabetes mellitus, N (%)
  Type I
3 (0.5%)
  Type II
100 (16.8%)
  No
491 (82.7%)
Cardiac history, N (%)
  Yes
61 (10.3%)
  No
533 (89.7%)
Pulmonary history, N (%)
  Yes
67 (11.3%)
  No
527 (88.7%)
ASA3 classification, N (%)
  I
48 (8.1%)
  II
345 (58.1%)
  III
193 (32.5%)
  IV
8 (1.3%)
Operation indication, N (%)
  Colorectal cancer
579 (97.5%)
    Local recurrence
5 (0.8%)
  Anal cancer
3 (0.5%)
  Ovarian cancer
4 (0.7%)
  Other4
8 (1.3%)
Stage of disease5, N (%)
  I
178 (30.0%)
  II
181 (30.5%)
  III
180 (30.3%)
  IV
35 (5.9%)
1SD standard deviation
2BMI body mass index
3ASA American Society of Anesthesiologists
4Indications classified as ‘other’: lymphoma (n = 2), sarcoma (n = 2), melanoma (n = 1), appendiceal carcinoma (n = 2), endometrial carcinoma (n = 1)
5Only applicable for primary tumours, colorectal cancer
Table 2
Surgical details (N = 5 94)
Surgical procedure, N (%)
  Ileocecal resection
2 (0.3%)
  Right hemicolectomy
199 (33.5%)
  Left hemicolectomy
46 (7.7%)
  Sigmoid resection
117 (19.7%)
  LAR1
99 (16.6%)
  APR2
70 (11.8%)
  TME3
25 (4.2%)
  Exenteration
12 (2.0%)
  Other4
24 (4.0%)
Priority of procedure, N (%)
  Acute
46 (7.7%)
  Elective
548 (92.3%)
Type of procedure, N (%)
  Laparoscopic
353 (59.4%)
  Robot (assisted)
22 (3.7%)
  Conversion
64 (10.8%)
  Open
155 (26.1%)
Operative time in minutes, mean (SD5)
210 (92)
Primary anastomosis, N (%)
419 (70.5%)
Stoma, N (%)
  Ileostomy
93 (15.7%)
  Colostomy
154 (25.9%)
  Stoma prior to resection
12 (2.0%)
Postoperative stay (d), (range)
7 (3–77)
1LAR low anterior resection
2APR abdominoperineal resection
3TME total mesorectal excision
4The following procedures were classified as ‘other’: transversectomy (n = 8), (sub)total colectomy (n = 9), right hemicolectomy combined with sigmoid resection (n = 5), right hemicolectomy combined with APR (n = 1), pelvic exenteration paired with right hemicolectomy (n = 1)
5SD standard deviation

Postoperative complications

The occurrence of postoperative complications is presented in Table 3. Of the 594 patients, 364 (61.3%) had recovered without any postoperative complications, 134 (22.6%) encountered minor (wound) complications and 96 (16.2%) suffered from major complications. Three patients (0.5%) died within 30 days after the procedure due to postoperative complications (Table 4). Among the 443 patients with a primary anastomosis in situ, 27 (6.1%) developed an anastomotic leakage. Out of these patients, 23 required re-operation. The remaining four patients were successfully managed conservatively through drainage and/or antibiotic therapy. The most frequently reported surgical complications were ileus (N = 89, 15%), an intra-abdominal abscess (N = 34, 5.7%) and surgical site infection (N = 29, 4.9%). Thirty-five (5.9%) patients had to be readmitted to the hospital within 30 days after initial discharge. The median length of hospital stay was 7 days, ranging from 3 to 77 days. Fifteen patients (2.5%) were discharged to their homes on the third postoperative day (POD) without any complications, 83 patients (14%) were discharged on POD 4 and 101 patients (17%) on POD 5.
Table 3
Postoperative complications (N = 594)
No complications, N (%)
364 (61.3%)
Surgical complications, N (%)
  Anastomotic leakage1
27 (6.1%)
    Re-operation
23 (3.9%)
  Intra-abdominal abscess
34 (5.7%)
  Ileus
89 (15.0%)
  Surgical site infection
29 (4.9%)
  Fascia dehiscence
11 (1.9%)
  High output stoma
14 (2.4%)
  Bleeding
14 (2.4%)
General complications, N (%)
  Urinary tract infection
20 (3.4%)
  Bladder retention
19 (3.2%)
  Central line infection
6 (1.0%)
  Pneumonia
40 (6.7%)
  Thrombo-embolic events2
9 (1.5%)
  Delirium
10 (1.7%)
  Readmissions to hospital
35 (5.9%)
  Mortality
3 (0.5%)
  Other3
18 (3.0%)
1Only patients who had an anastomosis were considered for the percentage of anastomotic leakages
2Complications classified as thrombo-embolic events were pulmonary embolism (n = 5), deep venous thrombosis (n = 2), arterial thrombosis (n = 1) and cerebrovascular accident (n = 1)
3Complications classified as ‘other’ were pancreatic leakage (n = 5), hypertension (n = 3), electrolyte disturbances (n = 2), perioperative injury of the urinary tract (n = 2), abdominal compartment syndrome (n = 1), intestinal ischemia (n = 1), burn injury (n = 1), hearing loss (n = 1), atelectasis (n = 1) and airway obstruction (n = 1)
Table 4
Complication classification (N = 594)
Clavien-Dindo classification, N (%)
No complication
364 (61.3%)
Grade I
40 (6.7%)
Grade II
94 (15.8%)
Grade IIIa
33 (5.6%)
Grade IIIb
30 (5.1%)
Grade IV
26 (4.4%)
Grade IVa
4 (0.7%)
Grade IVb
0
Grade V
3 (0.5%)

C-reactive protein (CRP)

CRP levels reach their peak on the POD 2, with a mean value of 166 mg/L (SD 88.6), gradually decreasing over the subsequent days. The data were stratified to analyse the CRP levels in patients with no, minor and major complications (Fig. 1). The peak CRP levels on POD 2 were 140 mg/L, 195 mg/L and 225 mg/L for patients without complications, with minor and with major complications, respectively.
Figure 2 displays the mean CRP levels for acute and elective procedures on each postoperative day. Mean CRP peaked for both acute and elective procedures on POD 2 to 226 mg/L and 161 mg/L, respectively. Patients undergoing acute procedures had higher mean CRP levels on PODs 1, 2 and 3 compared to patients undergoing elective procedures; however, we must report that most acute cases were operated by laparotomy.
The mean CRP per surgical procedure type is presented in Fig. 3. All procedure types demonstrated a peak in mean CRP levels on POD 2, with primary open procedures showing the highest peak at 214 mg/L, followed by converted procedures at 194 mg/L, robot-assisted procedures at 167 mg/L and laparoscopic procedures with the lowest peak at 140 mg/L. It should be noted that all robot-assisted procedures were rectal resections.
When stratified by clinical stage of disease, CRP levels displayed a significantly higher peak on POD 2 for patients with stage IV disease, with a mean CRP of 198 mg/L. Stages II and III exhibited similar peak values of 171 mg/L and 169 mg/L on POD 2, respectively. Stage I patients demonstrated the lowest peak at 147 mg/L (Fig. 4).
Receiver operating characteristic (ROC) curve analysis was performed for all patients on POD 2 and POD 3. The optimal cut-off was determined using Youden’s J index. On POD 2, the established cut-off was 170 mg/L with a sensitivity of 68% and specificity of 62%. Notably, the specificity increased on POD 3, with an established cut-off of 152 mg/L, sensitivity 69% and specificity 74% (Table 5). If T4 tumors, open and acute resections were excluded, the area under the curve (AUC) would be even higher.
Table 5
ROC curve analysis for POD 2 and POD 3 to assess cut-off values for CRP as a predictor for major complications
     
95% CI1
 
 
CRP cut-off (mg/L)
Sensitivity
Specificity
AUC2
Lower bound
Upper bound
POD 2
170
0.68
0.62
0.71
0.65
0.77
POD 3
152
0.69
0.74
0.74
0.69
0.81
CRP C-reactive protein, POD postoperative day
1CI confidence interval
2AUC area under the curve

Leucocytes

The leucocyte levels also demonstrate a peak on POD 2 for patients with minor or major complications (Fig. 5). For these patient groups, leucocyte levels reached a peak of 11.5 10^9/L and 11.3 10^9/L, respectively. Leucocyte levels gradually decreased over the subsequent days in a pattern comparable to the CRP levels. In patients without complications, the level of leucocytes gradually decreased from POD 1 onwards.

Modified Early Warning Score (MEWS)

The MEWS values for each postoperative day (POD) ranged from 0 to 10, with a mean MEWS variation of 0.5–1.5 during the initial five postoperative days. We acknowledge that these minor differences may not have significant clinical relevance.

Logistic regression analyses

Confounder-adjusted logistic regression analyses were performed on the first three postoperative days, since most patients without complications were discharged on POD 3. The results of these analyses are depicted in Table 6. A statistically significant association was observed between CRP levels and major complications on PODs 1, 2 and 3 (p = 0.03, p = 0.03 and p < 0.001, respectively). The same association was demonstrated for the change in CRP levels compared to the preceding day (Δ CRP) on POD 2 and 3 (p < 0.001). Leucocyte levels on POD 3 showed a statistically significant association with major complications (p = 0.003), while the Δ leucocytes was only significant on POD 2 (p < 0.001). The association between MEWS and major complications was only statistically significant on POD 2 (p = 0.02).
Table 6
Multivariable logistic regression analyses assessing the associations of (delta) CRP, (delta) leucocytes and MEWS, measured on POD 1, 2 or 3, with major postoperative complications
 
POD 1
POD 2
POD 3
OR
95% CI
p
OR
95% CI
p
OR
95% CI
p
CRP
1.01
1–1.01
0.03
1.01
1–1.01
0.03
1.01
1.01–1.012
 < 0.001
Δ CRP1
N/A
N/A
N/A
1.01
1.01–1.02
 < 0.001
1.01
1.01–1.02
 < 0.001
Leucocytes
0.96
0.89–1.03
0.26
1.00
0.92–1.09
0.98
1.11
1.04–1.19
0.003
Δ Leucocytes2
N/A
N/A
N/A
1.27
1.13–1.43
 < 0.001
1.03
0.92–1.15
0.62
MEWS
1.10
0.78–1.54
0.59
1.21
1.03–1.42
0.02
1.20
0.99–1.44
0.06
1Delta CRP on POD 2 equals CRP on POD 2 minus CRP on POD 1
Delta CRP on POD 3 equals CRP on POD 3 minus CRP on POD 2
2Delta leucocytes on POD 2 equals leucocytes on POD 2 minus leucocytes on POD 1
Delta leucocytes on POD 3 equals leucocytes on POD 3 minus leucocytes on POD 2
CI confidence interval, CRP C-reactive protein, POD postoperative day, N/A not applicable
Depicting the primary model, with correction for sex, age, stage of disease, BMI, diabetes mellitus and active smoking. Statistically significant results were defined as p ≤ 0.05 and are printed in bold

Discussion

In this study, we analysed the levels of postoperative CRP, leucocytes and vital signs in 594 consecutive patients who underwent oncological colorectal resections. Our findings support that postoperative CRP levels can serve as a predictive factor for major complications. Specifically, we identified cut-off values of 170 mg/L on POD 2 and 152 mg/L on POD 3. Furthermore, we found a statistically significant association between changes in both CRP and leucocyte levels and MEWS on POD 2 with the occurrence of major complications.
While previous research has primarily focused on establishing cut-off values for POD 3, only a limited number of studies have proposed cut-off values for POD 2 [11, 13, 19]. However, no consensus has been reached on the optimal cut-off point for any postoperative day. The suggested CRP values in available literature range from 140 to 220 mg/L [10, 11, 16, 26]. Our identified cut-off value of 152 mg/L on POD 3 falls within this range. Moreover, other studies have demonstrated that an increase of ≥ 50 mg/L between any two postoperative days, irrespective of the absolute CRP value, predicts the occurrence of complications [12, 17].
CRP levels are higher in patients who undergo acute resections. Open resections are more frequently performed in an acute setting, which contributes to the observed elevation in CRP levels. This is partly due to the inflammatory response in the indication for surgery (i.e. near blowout, perforation or peritonitis), and partly contributed to the fact that open surgery generates higher CRP levels than minimally invasive procedures [27, 28]. In our study population, patients who underwent robotic resections exhibited slightly higher CRP levels than those who underwent laparoscopic procedures. Additionally, CRP levels further increased on POD 5 in the robotic group. This finding can be partially attributed to the longer operating time in the robotic group, as well as the fact that only rectal resections (no colon resections) were performed [29]. The second peak in CRP levels on POD 5 may be attributed to the fact that only patients who experienced complications remained hospitalized on day 5 after a robotic resection.
A more advanced clinical stage of disease is correlated with higher levels of postoperative serum CRP. This association has been demonstrated to be significant in relation to larger tumour diameter, therefore more open resections (including extra-anatomical resections due to T4 stage), longer operation time and more blood loss [30]. Several studies have also indicated that elevated postoperative CRP levels are significantly associated with long-term outcomes such as disease-free and overall survival, independent of complications [3133].
Limited research has been conducted on the added value of the white blood cell count (WBC) or vital signs in predicting complications following colorectal surgery. Some studies suggest that WBC is not an independent risk for factor major complications, but becomes relevant when combined with elevated CRP levels [18]. Others argue that the addition of WBC to CRP does not improve the negative predictive value for anastomotic leakage, or that the trajectory of WBC over a 5-day period should be given more importance [12, 34]. Our findings suggest that the absolute WBC count on POD 2 may not have a significant association with major complications, but the change in WBC compared to POD 1 does exhibit a statistically significant association.
Reports on the value of vital signs in detecting complications vary considerably. Some studies report that vital sign abnormalities are very common after major abdominal surgery and therefore poor predictors of complications such as anastomotic leakage [35, 36]. Others argue that vital signs, particularly heart rate, respiratory rate and body temperature are associated with early detection of complications [37, 38]. Our study found that the MEWS, which incorporates heart rate, respiratory rate, temperature and blood pressure, exhibits a significant association with major complications when measured on POD 2 [24].
Certain limitations of the present study have to be acknowledged, including its retrospective design. Furthermore, no external validation has been conducted. The observed biases in the composition of study groups, where all robot-assisted procedures were rectal resections—typically elective and performed by experienced surgeons—while primary open procedures were predominantly performed in acute settings and on patients with locally advanced tumours, represent inherent limitations that may influence the interpretation of the results. These disparities introduce potential confounding factors, impacting postoperative CRP and leucocyte levels irrespective of postoperative complications. Nevertheless, the study’s substantial population size and adequate correction for confounding factors enhance its power and contribute valuable insights into the relationships examined.
Future prospective research is warranted to not only identify the optimal toolkit for early detection of postoperative complications but also ushering us into a new era of ambulatory colon resections and same day discharge, while ensuring adequate patient monitoring and treatment.

Conclusion

CRP on POD 3, as previously established, serves as a predictive factor for major complications following oncological colorectal resections. However, the value on POD 2 is also highly indicative, which is of significant importance in an era where there is a trend towards 48- or even 24-h admissions for colorectal surgery. Particularly in uncomplicated, laparoscopic colorectal resections that have followed standard resection planes, a CRP above the cut-off value of 170 mg/L for CRP on POD 2, or ≥ 152 mg/L on POD 3 warrants vigilant patient monitoring.

Acknowledgements

The authors would like to express their gratitude for the technical support and expert advice on data management of Cédric Gillissen and Joost Huiskens.

Declarations

Ethics approval

Approval of the Medical Ethics Committee from Maastricht University and the Maastricht University Medical Centre was obtained.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Literatur
1.
Zurück zum Zitat Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2013) GLOBOCAN 2012 v1.0. Cancer incidence and mortality worldwide: IARC CancerBase 11 Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2013) GLOBOCAN 2012 v1.0. Cancer incidence and mortality worldwide: IARC CancerBase 11
2.
Zurück zum Zitat Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F (2017) Global patterns and trends in colorectal cancer incidence and mortality. Gut 66(4):683–691CrossRefPubMed Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F (2017) Global patterns and trends in colorectal cancer incidence and mortality. Gut 66(4):683–691CrossRefPubMed
3.
Zurück zum Zitat Beets-Tan R, Leijtens J, Beets GL (2011) Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. Clin Oncol 29:4633–4640 Beets-Tan R, Leijtens J, Beets GL (2011) Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. Clin Oncol 29:4633–4640
4.
Zurück zum Zitat Chiarello MM, Fransvea P, Cariati M, Adams NJ, Bianchi V, Brisinda G (2022) Anastomotic leakage in colorectal cancer surgery. Surg Oncol 40:101708 Chiarello MM, Fransvea P, Cariati M, Adams NJ, Bianchi V, Brisinda G (2022) Anastomotic leakage in colorectal cancer surgery. Surg Oncol 40:101708
5.
Zurück zum Zitat Kirchhoff P, Clavien P-A, Hahnloser D (2010) Complications in colorectal surgery: risk factors and preventive strategies. Patient Saf Surg 4(1):1–13CrossRef Kirchhoff P, Clavien P-A, Hahnloser D (2010) Complications in colorectal surgery: risk factors and preventive strategies. Patient Saf Surg 4(1):1–13CrossRef
6.
Zurück zum Zitat Bertelsen CA, Andreasen A, Jørgensen T, Harling H, Group DCC (2010) Anastomotic leakage after curative anterior resection for rectal cancer: short and long-term outcome. Colorectal Dis. 12(7Online):e76–e81CrossRefPubMed Bertelsen CA, Andreasen A, Jørgensen T, Harling H, Group DCC (2010) Anastomotic leakage after curative anterior resection for rectal cancer: short and long-term outcome. Colorectal Dis. 12(7Online):e76–e81CrossRefPubMed
7.
Zurück zum Zitat Foppa C, Ng SC, Montorsi M, Spinelli A (2020) Anastomotic leak in colorectal cancer patients: new insights and perspectives. Eur J Surg Oncol 46(6):943–954CrossRefPubMed Foppa C, Ng SC, Montorsi M, Spinelli A (2020) Anastomotic leak in colorectal cancer patients: new insights and perspectives. Eur J Surg Oncol 46(6):943–954CrossRefPubMed
8.
Zurück zum Zitat Koedam TW, Bootsma BT, Deijen CL, van de Brug T, Kazemier G, Cuesta MA et al (2022) Oncological outcomes after anastomotic leakage after surgery for colon or rectal cancer: increased risk of local recurrence. Ann Surg 275(2):e420–e427CrossRefPubMed Koedam TW, Bootsma BT, Deijen CL, van de Brug T, Kazemier G, Cuesta MA et al (2022) Oncological outcomes after anastomotic leakage after surgery for colon or rectal cancer: increased risk of local recurrence. Ann Surg 275(2):e420–e427CrossRefPubMed
9.
Zurück zum Zitat Mirnezami A, Mirnezami R, Chandrakumaran K, Sasapu K, Sagar P, Finan P (2011) Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis. Ann Surg 253(5):890–899CrossRefPubMed Mirnezami A, Mirnezami R, Chandrakumaran K, Sasapu K, Sagar P, Finan P (2011) Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis. Ann Surg 253(5):890–899CrossRefPubMed
10.
Zurück zum Zitat Singh P, Zeng I, Srinivasa S, Lemanu D, Connolly A, Hill A (2014) Systematic review and meta-analysis of use of serum C-reactive protein levels to predict anastomotic leak after colorectal surgery. J Br Surg 101(4):339–346CrossRef Singh P, Zeng I, Srinivasa S, Lemanu D, Connolly A, Hill A (2014) Systematic review and meta-analysis of use of serum C-reactive protein levels to predict anastomotic leak after colorectal surgery. J Br Surg 101(4):339–346CrossRef
11.
Zurück zum Zitat Messias BA, Botelho RV, Saad SS, Mocchetti ER, Turke KC, Waisberg J (2020) Serum C-reactive protein is a useful marker to exclude anastomotic leakage after colorectal surgery. Sci Rep 10(1):1–8CrossRef Messias BA, Botelho RV, Saad SS, Mocchetti ER, Turke KC, Waisberg J (2020) Serum C-reactive protein is a useful marker to exclude anastomotic leakage after colorectal surgery. Sci Rep 10(1):1–8CrossRef
12.
Zurück zum Zitat Smith SR, Pockney P, Holmes R, Doig F, Attia J, Holliday E et al (2018) Biomarkers and anastomotic leakage in colorectal surgery: C-reactive protein trajectory is the gold standard. ANZ J Surg 88(5):440–444CrossRefPubMed Smith SR, Pockney P, Holmes R, Doig F, Attia J, Holliday E et al (2018) Biomarkers and anastomotic leakage in colorectal surgery: C-reactive protein trajectory is the gold standard. ANZ J Surg 88(5):440–444CrossRefPubMed
13.
Zurück zum Zitat Straatman J, Harmsen AM, Cuesta MA, Berkhof J, Jansma EP, Van der Peet DL (2015) Predictive value of C-reactive protein for major complications after major abdominal surgery: a systematic review and pooled-analysis. PLoS ONE 10(7):e0132995CrossRefPubMedPubMedCentral Straatman J, Harmsen AM, Cuesta MA, Berkhof J, Jansma EP, Van der Peet DL (2015) Predictive value of C-reactive protein for major complications after major abdominal surgery: a systematic review and pooled-analysis. PLoS ONE 10(7):e0132995CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Gans SL, Atema JJ, Van Dieren S, Koerkamp BG, Boermeester MA (2015) Diagnostic value of C-reactive protein to rule out infectious complications after major abdominal surgery: a systematic review and meta-analysis. Int J Colorectal Dis 30:861–873CrossRefPubMedPubMedCentral Gans SL, Atema JJ, Van Dieren S, Koerkamp BG, Boermeester MA (2015) Diagnostic value of C-reactive protein to rule out infectious complications after major abdominal surgery: a systematic review and meta-analysis. Int J Colorectal Dis 30:861–873CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Cole DS, Watts A, Scott-Coombes D, Avades T (2008) Clinical utility of peri-operative C-reactive protein testing in general surgery. Ann R Coll Surg Engl 90(4):317–321CrossRefPubMedPubMedCentral Cole DS, Watts A, Scott-Coombes D, Avades T (2008) Clinical utility of peri-operative C-reactive protein testing in general surgery. Ann R Coll Surg Engl 90(4):317–321CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Straatman J, de Weerdesteijn EdW, Tuynman JB, Cuesta MA, van der Peet DL (2016) C-reactive protein as a marker for postoperative complications. Are there differences in emergency and elective colorectal surgery? Dis Colon Rectum. 59(1):35–41CrossRefPubMed Straatman J, de Weerdesteijn EdW, Tuynman JB, Cuesta MA, van der Peet DL (2016) C-reactive protein as a marker for postoperative complications. Are there differences in emergency and elective colorectal surgery? Dis Colon Rectum. 59(1):35–41CrossRefPubMed
17.
Zurück zum Zitat Stephensen B, Reid F, Shaikh S, Carroll R, Smith S, Pockney P (2020) C-reactive protein trajectory to predict colorectal anastomotic leak: PREDICT Study. J Br Surg 107(13):1832–1837CrossRef Stephensen B, Reid F, Shaikh S, Carroll R, Smith S, Pockney P (2020) C-reactive protein trajectory to predict colorectal anastomotic leak: PREDICT Study. J Br Surg 107(13):1832–1837CrossRef
18.
Zurück zum Zitat Liesenfeld LF, Sauer P, Diener MK, Hinz U, Schmidt T, Müller-Stich BP et al (2020) Prognostic value of inflammatory markers for detecting anastomotic leakage after esophageal resection. BMC Surg 20(1):1–11CrossRef Liesenfeld LF, Sauer P, Diener MK, Hinz U, Schmidt T, Müller-Stich BP et al (2020) Prognostic value of inflammatory markers for detecting anastomotic leakage after esophageal resection. BMC Surg 20(1):1–11CrossRef
19.
Zurück zum Zitat Warschkow R, Beutner U, Steffen T, Müller SA, Schmied BM, Güller U et al (2012) Safe and early discharge after colorectal surgery due to C-reactive protein: a diagnostic meta-analysis of 1832 patients. Ann Surg 256(2):245–250CrossRefPubMed Warschkow R, Beutner U, Steffen T, Müller SA, Schmied BM, Güller U et al (2012) Safe and early discharge after colorectal surgery due to C-reactive protein: a diagnostic meta-analysis of 1832 patients. Ann Surg 256(2):245–250CrossRefPubMed
20.
Zurück zum Zitat Tweed TT, Sier MA, Daher I, Bakens MJ, Nel J, Bouvy ND et al (2022) Accelerated 23-h enhanced recovery protocol for colon surgery: the CHASE-study. Sci Rep 12(1):20707ADSCrossRefPubMedPubMedCentral Tweed TT, Sier MA, Daher I, Bakens MJ, Nel J, Bouvy ND et al (2022) Accelerated 23-h enhanced recovery protocol for colon surgery: the CHASE-study. Sci Rep 12(1):20707ADSCrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Gignoux B, Gosgnach M, Lanz T, Vulliez A, Blanchet M-C, Frering V et al (2019) Short-term outcomes of ambulatory colectomy for 157 consecutive patients. Ann Surg 270(2):317–321CrossRefPubMed Gignoux B, Gosgnach M, Lanz T, Vulliez A, Blanchet M-C, Frering V et al (2019) Short-term outcomes of ambulatory colectomy for 157 consecutive patients. Ann Surg 270(2):317–321CrossRefPubMed
22.
Zurück zum Zitat Kant N, Peters GM, Voorthuis BJ, Groothuis-Oudshoorn CG, Koning MV, Witteman BP et al (2022) Continuous vital sign monitoring using a wearable patch sensor in obese patients: a validation study in a clinical setting. J Clin Monit Comput 36(5):1449–1459CrossRefPubMed Kant N, Peters GM, Voorthuis BJ, Groothuis-Oudshoorn CG, Koning MV, Witteman BP et al (2022) Continuous vital sign monitoring using a wearable patch sensor in obese patients: a validation study in a clinical setting. J Clin Monit Comput 36(5):1449–1459CrossRefPubMed
23.
Zurück zum Zitat Doyle DJ, Goyal A, Bansal P, Garmon EH (2021) American Society of Anesthesiologists classification. StatPearls Publishing, Statpearls Doyle DJ, Goyal A, Bansal P, Garmon EH (2021) American Society of Anesthesiologists classification. StatPearls Publishing, Statpearls
24.
Zurück zum Zitat Subbe CP, Kruger M, Rutherford P, Gemmel L (2001) Validation of a modified Early Warning Score in medical admissions. QJM 94(10):521–526CrossRefPubMed Subbe CP, Kruger M, Rutherford P, Gemmel L (2001) Validation of a modified Early Warning Score in medical admissions. QJM 94(10):521–526CrossRefPubMed
25.
Zurück zum Zitat Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Plat VD, Voeten DM, Daams F, van der Peet DL, Straatman J (2021) C-reactive protein after major abdominal surgery in daily practice. Surgery 170(4):1131–1139CrossRefPubMed Plat VD, Voeten DM, Daams F, van der Peet DL, Straatman J (2021) C-reactive protein after major abdominal surgery in daily practice. Surgery 170(4):1131–1139CrossRefPubMed
27.
Zurück zum Zitat Shibata J, Ishihara S, Tada N, Kawai K, Tsuno N, Yamaguchi H et al (2015) Surgical stress response after colorectal resection: a comparison of robotic, laparoscopic, and open surgery. Tech Coloproctol 19:275–280CrossRefPubMed Shibata J, Ishihara S, Tada N, Kawai K, Tsuno N, Yamaguchi H et al (2015) Surgical stress response after colorectal resection: a comparison of robotic, laparoscopic, and open surgery. Tech Coloproctol 19:275–280CrossRefPubMed
28.
Zurück zum Zitat Pedrazzani C, Moro M, Mantovani G, Lazzarini E, Conci S, Ruzzenente A et al (2017) C-reactive protein as early predictor of complications after minimally invasive colorectal resection. J Surg Res 210:261–268CrossRefPubMed Pedrazzani C, Moro M, Mantovani G, Lazzarini E, Conci S, Ruzzenente A et al (2017) C-reactive protein as early predictor of complications after minimally invasive colorectal resection. J Surg Res 210:261–268CrossRefPubMed
29.
Zurück zum Zitat Corbellini C, Biffi R, Luca F, Chiappa A, Costa S, Bertani E et al (2016) Open, laparoscopic, and robotic surgery for rectal cancer: medium-term comparative outcomes from a multicenter study. Tumori J 102(4):414–421CrossRef Corbellini C, Biffi R, Luca F, Chiappa A, Costa S, Bertani E et al (2016) Open, laparoscopic, and robotic surgery for rectal cancer: medium-term comparative outcomes from a multicenter study. Tumori J 102(4):414–421CrossRef
30.
Zurück zum Zitat Shibutani M, Okazaki Y, Maeda K, HirakawA K, Ohira M (2021) A high postoperative serum C-reactive protein level has a negative impact on long-term survival, regardless of postoperative infectious complications, in patients who undergo laparoscopic surgery for colorectal cancer. Anticancer Res 41(3):1593–1598CrossRefPubMed Shibutani M, Okazaki Y, Maeda K, HirakawA K, Ohira M (2021) A high postoperative serum C-reactive protein level has a negative impact on long-term survival, regardless of postoperative infectious complications, in patients who undergo laparoscopic surgery for colorectal cancer. Anticancer Res 41(3):1593–1598CrossRefPubMed
31.
Zurück zum Zitat McSorley ST, Watt DG, Horgan PG, McMillan DC (2016) Postoperative systemic inflammatory response, complication severity, and survival following surgery for colorectal cancer. Ann Surg Oncol 23:2832–2840CrossRefPubMedPubMedCentral McSorley ST, Watt DG, Horgan PG, McMillan DC (2016) Postoperative systemic inflammatory response, complication severity, and survival following surgery for colorectal cancer. Ann Surg Oncol 23:2832–2840CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Matsubara D, Arita T, Nakanishi M, Kuriu Y, Murayama Y, Kudou M et al (2020) The impact of postoperative inflammation on recurrence in patients with colorectal cancer. Int J Clin Oncol 25:602–613CrossRefPubMed Matsubara D, Arita T, Nakanishi M, Kuriu Y, Murayama Y, Kudou M et al (2020) The impact of postoperative inflammation on recurrence in patients with colorectal cancer. Int J Clin Oncol 25:602–613CrossRefPubMed
33.
Zurück zum Zitat Yasui K, Shida D, Nakamura Y, Ahiko Y, Tsukamoto S, Kanemitsu Y (2021) Postoperative, but not preoperative, inflammation-based prognostic markers are prognostic factors in stage III colorectal cancer patients. Br J Cancer 124(5):933–941CrossRefPubMed Yasui K, Shida D, Nakamura Y, Ahiko Y, Tsukamoto S, Kanemitsu Y (2021) Postoperative, but not preoperative, inflammation-based prognostic markers are prognostic factors in stage III colorectal cancer patients. Br J Cancer 124(5):933–941CrossRefPubMed
34.
Zurück zum Zitat El Zaher HA, Ghareeb WM, Fouad AM, Madbouly K, Fathy H, Vedin T et al (2022) Role of the triad of procalcitonin, C-reactive protein, and white blood cell count in the prediction of anastomotic leak following colorectal resections. World J Surg Oncol 20(1):1–10 El Zaher HA, Ghareeb WM, Fouad AM, Madbouly K, Fathy H, Vedin T et al (2022) Role of the triad of procalcitonin, C-reactive protein, and white blood cell count in the prediction of anastomotic leak following colorectal resections. World J Surg Oncol 20(1):1–10
35.
Zurück zum Zitat Twohig K, Ajith A, Mayampurath A, Hyman N, Shogan BD (2021) Abnormal vital signs after laparoscopic colorectal surgery: more common than you think. Am J Surg 221(3):654–658CrossRefPubMed Twohig K, Ajith A, Mayampurath A, Hyman N, Shogan BD (2021) Abnormal vital signs after laparoscopic colorectal surgery: more common than you think. Am J Surg 221(3):654–658CrossRefPubMed
36.
Zurück zum Zitat Erb L, Hyman NH, Osler T (2014) Abnormal vital signs are common after bowel resection and do not predict anastomotic leak. J Am Coll Surg 218(6):1195–1199CrossRefPubMed Erb L, Hyman NH, Osler T (2014) Abnormal vital signs are common after bowel resection and do not predict anastomotic leak. J Am Coll Surg 218(6):1195–1199CrossRefPubMed
37.
Zurück zum Zitat Luo J, Wu H, Jiang Y, Yang Y, Yuan J, Tong Q (2021) The role of heart rate, body temperature, and respiratory rate in predicting anastomotic leakage following surgery for rectal cancer. Mediat Inflamm 2021:1–6 Luo J, Wu H, Jiang Y, Yang Y, Yuan J, Tong Q (2021) The role of heart rate, body temperature, and respiratory rate in predicting anastomotic leakage following surgery for rectal cancer. Mediat Inflamm 2021:1–6
38.
Zurück zum Zitat Den Dulk M, Witvliet M, Kortram K, Neijenhuis P, De Hingh I, Engel A et al (2013) The DULK (D utch leakage) and modified DULK score compared: actively seek the leak. Colorectal Dis 15(9):e528–e533 Den Dulk M, Witvliet M, Kortram K, Neijenhuis P, De Hingh I, Engel A et al (2013) The DULK (D utch leakage) and modified DULK score compared: actively seek the leak. Colorectal Dis 15(9):e528–e533
Metadaten
Titel
The value of C-reactive protein, leucocytes and vital signs in detecting major complications after oncological colorectal surgery
verfasst von
Anke H. C. Gielen
Maud Schoenmakers
Stephanie O. Breukink
Bjorn Winkens
Jischmaël van der Horst
Kevin P. Wevers
Jarno Melenhorst
Publikationsdatum
01.12.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 1/2024
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-024-03266-3

Weitere Artikel der Ausgabe 1/2024

Langenbeck's Archives of Surgery 1/2024 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.